1,4,6-androstatrien-3,17-dione

Also Known As:

ATD dione; androstatrien-dione

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Body Weight (Weight, Body) 07/01/2011 - "To determine the effect of estrogen on the growth of the baculum, the aromatase inhibitor 1,4,6-androstatrien-3,17-dione (ATD) was subcutaneously injected daily into pregnant rats from Days 19 to 23 of gestation and into pups on postnatal Days 1, 3, 5, 7, and 9. On Day 10, the length of the baculum in the ATD-treated rats was significantly shorter than that in the controls, although the body weight did not change. "
2.	Hypoxia (Hypoxemia) 07/01/2015 - "Moreover, treatment with 1,4,6-androstatrien-3,17-dione, an aromatase inhibitor, increased hypothalamic O2(·-) production and nNOS expression in normoxic control fish; whereas estradiol-17β treatment significantly reduced O2(·-) production and nNOS expression in hypoxia-exposed fish. "